AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company, which is focused on discovery, production and commercialization of a range of prescription drugs. It develops products related to therapy areas such as respiratory, cardiovascular, renal and metabolic diseases, cancer, autoimmune, infection, and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals, and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors, and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa, and Australasia.
The report provides information and insights into AstraZeneca's tech activities, including:
- Insights of its digital transformation strategies and innovation programs.
- Overview of technology initiatives covering partnerships and product launches.
- Insights on each technology initiative including technology theme, objective, and benefits.
- Details of estimated ICT budgets and major ICT contracts.
Scope
- The report provides insights into company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Reasons to Buy
- Gain insights into AstraZeneca's tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches and partnerships.
Table of Contents
- Overview
- Digital Transformation Strategy
- Accelerators, Incubators, and Innovation Programs
- Technology Focus
- Technology Initiatives
- Acquisitions
- Partnership & Acquisition Network Map
- ICT Budget
- Key Executives
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Clinithink
- G42 Healthcare
- NVIDIA
- Genomenon
- Alexion Pharmaceuticals
- IBM
- LogicBio Therapeutics
- Ultivue
- MiNA Therapeutics
